Yasmin Post Marketing Surveillance

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Drospirenone and ethinyl estradiol combination

Criteria

Inclusion Criteria:

• Women who need oral contraceptive

Exclusion Criteria:

• Patient who belongs to contraindication listed on the product label.